{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

MS in focus magazine in print and online

MSIF recently reprinted out-of-stock English editions of MS in focus on fatigue (Issue 1) and bladder problems (Issue 2) and these are now available to be ordered for free.

read more

Do you use our My World of MS online community?

If so, have your say on its future development by taking part in our new survey.

read more

back to top

Profile of the Month : January 2008

Sonja Vranic

Age: 22
Country: Serbia
(studying in Denmark)
Occupation: Student
Year of diagnosis: 2005

"My name is Sonja and I am 22 years old. I would like to share my story of my life with MS."

English Italiano Espanol Deutsch Francais Russian

read more

back to top

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

The authors looked at a whole plant cannabis-based medicine in the treatment of spasticity in MS and found it to be useful.

authors: Collin C, Davies P, Mutiboko IK, Ratcliffe S; Sativex Spasticity in MS Study Group.

source: Eur J Neurol. 2007 Mar;14(3):290-6

read more

Interferon beta in secondary progressive multiple sclerosis: Daily clinical practice

This study on 146 people with secondary progressive MS found that patients with two or more relapses in the two years before starting treatment with interferon beta experienced a higher risk of clinical deterioration over time.

authors: Rio J, Tintore M, Nos C, Tellez N, Galan I, Pelayo R, Montalban X.

source: J Neurol. 2007 Mar 14

read more

Cortical atrophy is relevant in multiple sclerosis at clinical onset

The authors found that cortical brain atrophy occurs frequently and early in people with different subtypes of MS and was related to clinical deterioration.

authors: Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, McAuliffe MJ, Barachino L, Perini P, Fischl B, Battistin L, Gallo P.

source: J Neurol. 2007 Mar 14

read more

Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis

The authors looked at a newly developed imaging technique, T1 relaxometry, in patients with primary progressive MS. They found that it correlated with clinical disability over time and has prognostic potential.

authors: Manfredonia F, Ciccarelli O, Khaleeli Z, Tozer DJ, Sastre-Garriga J, Miller DH, Thompson AJ.

source: Arch Neurol. 2007 Mar;64(3):411-5

read more

The emotional and psychological impact of multiple sclerosis relapses

The author explores the various psychological impacts of acute MS relapses on patients and families.

authors: Kalb R

source: J Neurol Sci. 2007 Mar 8

read more

Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors

In this postmortem study, the authors found that some stem cells located in the adult brain are activated in response to MS giving rise to new myelin-producing cells. These stem cells could be the target for future therapeutic strategies in MS.

authors: Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Hoglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A.

source: Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4694-9

read more

back to top

UK MS Society cleans up at science communication "Oscars"

source: UK MS Society

The UK MS Society has swept the board at the UK Association of Medical Research Charities' (AMRC) 2007 Science Communication Awards.

read more

European MS Platform conference

source: EMSP

EMSP is holding a conference from 29-30 May 2007, in Brussels, Belgium, titled "Multiple Sclerosis Information Dividend".

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.